search
Back to results

EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS GIVEN TO NURSES

Primary Purpose

Nurse's Role, Training Group, Sensitivity

Status
Completed
Phase
Not Applicable
Locations
Turkey
Study Type
Interventional
Intervention
Training
Sponsored by
Ankara Yildirim Beyazıt University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Nurse's Role

Eligibility Criteria

18 Years - 64 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: She/He voluntarily agrees to participate in the research, Working as a nurse in the clinic and intensive care unit where blood transfusions are the most, Working for at least 6 months, Exclusion Criteria: Nurses working in the emergency and operating rooms, in clinics where blood transfusion is not performed the most, Being a new nurse, On maternity leave and maternity leave, Having an external assignment, Nurses working in the polyclinic,

Sites / Locations

  • Ankara Yıldırım Beyazıt University

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Intervention

Control

Arm Description

Five modules of training on hemovigilance were given in 5 hours. A pre-test was applied at the beginning of the training. The final test was done at the end of the training. One month later, the same test was applied again to measure the permanence of the training.

No training was provided. Only the pretest was administered one week after the posttest.

Outcomes

Primary Outcome Measures

Hemovigilance Information Form
It consists of fifteen questions about hemovigilance and hemovigilance system and definitions.
Information Form on Blood Transfusion Complications
This section consists of nine questions including transfusion complications.
Information Form on Blood Transfusion Applications
This section consists of sixteen questions including donor selection, questions about blood components, blood group and safe blood transfusion.

Secondary Outcome Measures

Full Information

First Posted
November 15, 2022
Last Updated
November 15, 2022
Sponsor
Ankara Yildirim Beyazıt University
search

1. Study Identification

Unique Protocol Identification Number
NCT05625672
Brief Title
EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS GIVEN TO NURSES
Official Title
EVALUATION OF THE EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Completed
Study Start Date
April 25, 2022 (Actual)
Primary Completion Date
May 26, 2022 (Actual)
Study Completion Date
July 8, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Ankara Yildirim Beyazıt University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The aim of the present study is to determine the effectiveness of hemovigilance module training given to nurses.
Detailed Description
125 nurses from the clinic and intensive care units, who received the most intensive blood transfusion from two different hospitals, were included in the study as the intervention and control groups. The control group was not trained. Only the pretest was administered one week after the posttest. After the pre-test was applied to the nurses in the intervention group, five modules of training, which lasted four hours, were given using interactive methods. Five modules of training were prepared by the researcher. These five modules are the 1st module of training; definition of hemovigilance, its aims, the development of hemovigilance in the world and in Turkey, and legal legislation, Module 2; Donor selection, Blood donation Process, Phlebotomy and Donor reactions, Module 3; blood, blood transfusion, its purpose, properties of blood and blood components, Blood transfusion process, Module 4; acute and delayed transfusion reactions and management, Module 5; It consists of the national hemovigilance system, the organization of the hemovigilance system at the hospital level, Traceability, Trace-back from the Patient to the Donor, and Look-back from the Donor to the Patient. the training was over, the final test was administered. One month later, this test was repeated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nurse's Role, Training Group, Sensitivity

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized, parallel-group, placebo-controlled study
Masking
None (Open Label)
Masking Description
None (Open Label)
Allocation
Randomized
Enrollment
125 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intervention
Arm Type
Experimental
Arm Description
Five modules of training on hemovigilance were given in 5 hours. A pre-test was applied at the beginning of the training. The final test was done at the end of the training. One month later, the same test was applied again to measure the permanence of the training.
Arm Title
Control
Arm Type
No Intervention
Arm Description
No training was provided. Only the pretest was administered one week after the posttest.
Intervention Type
Other
Intervention Name(s)
Training
Intervention Description
Hemovigilance module training
Primary Outcome Measure Information:
Title
Hemovigilance Information Form
Description
It consists of fifteen questions about hemovigilance and hemovigilance system and definitions.
Time Frame
5 hours or 1 month
Title
Information Form on Blood Transfusion Complications
Description
This section consists of nine questions including transfusion complications.
Time Frame
5 hours or 1 month
Title
Information Form on Blood Transfusion Applications
Description
This section consists of sixteen questions including donor selection, questions about blood components, blood group and safe blood transfusion.
Time Frame
5 hours or 1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: She/He voluntarily agrees to participate in the research, Working as a nurse in the clinic and intensive care unit where blood transfusions are the most, Working for at least 6 months, Exclusion Criteria: Nurses working in the emergency and operating rooms, in clinics where blood transfusion is not performed the most, Being a new nurse, On maternity leave and maternity leave, Having an external assignment, Nurses working in the polyclinic,
Facility Information:
Facility Name
Ankara Yıldırım Beyazıt University
City
Ankara
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

EFFICIENCY OF HEMOVIGILANCE MODULE TRAININGS GIVEN TO NURSES

We'll reach out to this number within 24 hrs